{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:17:48Z","timestamp":1790360268609,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007366","name":"Italian Multiple Sclerosis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["REPAIR FIS_00002258"],"award-info":[{"award-number":["REPAIR FIS_00002258"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jneuroim.2025.578622","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T02:48:23Z","timestamp":1745290103000},"page":"578622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Oligoclonal IgM band patterns in multiple sclerosis: A two-center study"],"prefix":"10.1016","volume":"404","author":[{"given":"Francesco","family":"Masi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Al Qudsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Visigalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Zardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Capello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Pio","family":"Dicembre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Uccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jneuroim.2025.578622_bb0005","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578622_bb0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/14737159.2024.2334849","article-title":"Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders","volume":"24","author":"Bauer","year":"2024","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"Pt 10","key":"10.1016\/j.jneuroim.2025.578622_bb0015","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/brain\/awu205","article-title":"Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation","volume":"137","author":"Beltran","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578622_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.immunol.20.100301.064833","article-title":"Origins and functions of B-1 cells with notes on the role of CD5","volume":"20","author":"Berland","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"18","key":"10.1016\/j.jneuroim.2025.578622_bb0025","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0161-5890(01)00025-6","article-title":"Role of natural and immune IgM antibodies in immune responses","volume":"37","author":"Boes","year":"2000","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578622_bb0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.biopha.2004.04.010","article-title":"Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them","volume":"58","author":"Bohm","year":"2004","journal-title":"Biomed. Pharmacother."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2025.578622_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2010.05.032","article-title":"The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands","volume":"226","author":"Bosca","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578622_bb0040","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1177\/1352458520981910","article-title":"Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability","volume":"27","author":"Capuano","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2025.578622_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cca.2014.08.004","article-title":"Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice","volume":"438","author":"Espino","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578622_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11111444","article-title":"Cerebrospinal fluid IgM and Oligoclonal IgG bands in multiple sclerosis: a meta-analysis of prevalence and prognosis","volume":"11","author":"Fonderico","year":"2021","journal-title":"Brain Sci."},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578622_bb0055","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1373\/clinchem.2007.089052","article-title":"Interlaboratory reproducibility of isoelectric focusing in oligoclonal band detection","volume":"53","author":"Franciotta","year":"2007","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2025.578622_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2005.07.002","article-title":"Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination","volume":"237","author":"Franciotta","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578622_bb0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00415-017-8716-4","article-title":"Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?","volume":"265","author":"Frau","year":"2018","journal-title":"J. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.jneuroim.2025.578622_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10072-017-3034-2","article-title":"Cerebrospinal fluid analysis and the determination of oligoclonal bands","volume":"38","author":"Gastaldi","year":"2017","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578622_bb0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(20)30067-3","article-title":"Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study","volume":"19","author":"He","year":"2020","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578622_bb0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41423-020-0445-4","article-title":"Homeostasis and regulation of autoreactive B cells","volume":"17","author":"Lee","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578622_bb0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12016-019-08746-9","article-title":"Natural antibodies: from first-line defense against pathogens to perpetual immune homeostasis","volume":"58","author":"Maddur","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578622_bb0090","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1515\/cclm-2020-1037","article-title":"Inter-center agreement in the interpretation of oligoclonal bands","volume":"59","author":"Mariotto","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578622_bb0095","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001047","article-title":"Predicting aggressive multiple sclerosis with intrathecal IgM synthesis among patients with a clinically isolated syndrome","volume":"8","author":"Monreal","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.jneuroim.2025.578622_bb0100","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1093\/brain\/awae260","article-title":"Serum biomarkers at disease onset for personalized therapy in multiple sclerosis","volume":"147","author":"Monreal","year":"2024","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578622_bb0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.26137","article-title":"Intrathecal immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis","volume":"90","author":"Oechtering","year":"2021","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578622_bb0110","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/jnnp.2005.086116","article-title":"Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis","volume":"77","author":"Perini","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"15","key":"10.1016\/j.jneuroim.2025.578622_bb0115","doi-asserted-by":"crossref","first-page":"e1439","DOI":"10.1212\/WNL.0000000000008237","article-title":"Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis","volume":"93","author":"Pfuhl","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578622_bb0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41582-019-0170-8","article-title":"Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis","volume":"15","author":"Rotstein","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578622_bb0125","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1468-1331.2007.01871.x","article-title":"Intrathecal IgM-synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event","volume":"14","author":"Schneider","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2025.578622_bb0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-5728(02)00360-0","article-title":"Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis","volume":"133","author":"Seidi","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578622_bb0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrneurol.2015.173","article-title":"Body fluid biomarkers for multiple sclerosis--the long road to clinical application","volume":"11","author":"Teunissen","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578622_bb0140","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1177\/1352458508095729","article-title":"Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis","volume":"14","author":"Thangarajh","year":"2008","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578622_bb0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2025.578622_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-1759(01)00492-6","article-title":"A sensitive and reproducible method for the detection of oligoclonal IgM bands","volume":"258","author":"Villar","year":"2001","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578622_bb0155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/WNL.59.4.555","article-title":"Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS","volume":"59","author":"Villar","year":"2002","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578622_bb0160","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1212\/WNL.58.5.824","article-title":"Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS","volume":"58","author":"Villar","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578622_bb0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.10441","article-title":"Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis","volume":"53","author":"Villar","year":"2003","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578622_bb0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1172\/JCI22833","article-title":"Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS","volume":"115","author":"Villar","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578622_bb0175","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/1352458510396922","article-title":"Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes","volume":"17","author":"Villar","year":"2011","journal-title":"Mult. Scler."},{"issue":"20","key":"10.1016\/j.jneuroim.2025.578622_bb0180","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical A","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578622_bb0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2362.1993.tb00753.x","article-title":"Human CD5-positive B cells in lymphoid malignancy and connective tissue diseases","volume":"23","author":"Youinou","year":"1993","journal-title":"Eur. J. Clin. Investig."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:11:42Z","timestamp":1762251102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"alternative-id":["S0165572825001031"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578622","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oligoclonal IgM band patterns in multiple sclerosis: A two-center study","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578622"}}